うつ病に対する受容とコミットメント療法 (ACT) の有効性: 体系的なレビューとメタ解析
Qinghuan Kong1, Shoumeng Yan1, Kexin Huang1
1School of Nursing, Jilin University, Changchun 130012, China.
Psychiatry research
|August 30, 2025
まとめ
受け入れとコミットメント療法 (ACT) は,うつ病の患者にうつ病と不安症状を大幅に軽減します. グループベースのACTは個々のセッションと比較して優れた効果を示し,有望な介入戦略を提供しました.
科学分野:
- 心理学
- 精神 的 な 健康
- 臨床研究
背景:
- 鬱病は世界の主要な 精神衛生問題であり 自殺率の増加につながっています
- 既存の研究は,うつ病に対する受け入れとコミットメント療法 (ACT) に関する合成された証拠を欠いている.
- 鬱病に対するACTの有効性を評価するために,体系的なレビューとメタ解析が必要でした.
研究 の 目的:
- 鬱病に対するACTに関するランダム化臨床試験 (RCT) を体系的にレビューし,メタ分析する.
- 鬱症状,不安症状,心理的柔軟性に対する ACT の影響を評価する.
- グループ対個人のACTの効果を比較する.
主な方法:
- 10つのデータベースを介して,体系的な文献検索が行われました.
- 10件のランダム化臨床試験 (RCT) がメタ解析に含まれた.
- 効果の大きさは,標準化された平均差 (SMD) を用いて95%の信頼区間で計算された.
主要な成果:
- ACTは,うつ病患者のうつ病症状 (SMD=- 0. 69) と不安症状 (SMD=- 0. 64) を有意に軽減しました.
- ACTは心理的な柔軟性 (SMD=0. 35) に著しく良い効果を示した.
- グループACTは,対照群と比較して,うつ病の症状を改善する上でより高い効果を示し,個々のACTを上回った.
結論:
- ACTは,うつ病の患者における鬱や不安の症状を軽減するための効果的な介入です.
- グループベースのACTは,うつ病の症状の管理において個々のACTよりも有益であるようです.
- これらの発見を強化し,臨床実践を導くために,さらに高品質で大規模なRCTを推奨する.
関連する概念動画
Cognitive Therapy
262
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
262
Rational Emotive Behavior Therapy
110
Cognitive-behavioral therapies (CBTs) are grounded in the belief that our thoughts profoundly influence our emotions and actions. Advocates of CBT emphasize three core assumptions: first, that cognitions are identifiable and measurable; second, that they are central to psychological functioning; and third, that irrational or maladaptive beliefs can be replaced with rational and adaptive ones. This transformative approach to therapy has paved the way for specific models such as Albert...
110
Electroconvulsive Therapy
182
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
182
Depression: Overview
331
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
331
Elements Crucial for Effective Psychotherapy
112
Research has highlighted several critical factors that influence the effectiveness of psychotherapy, such as the therapeutic alliance, the therapist, and the client.
The Therapeutic Alliance
The therapeutic alliance refers to the relationship between the therapist and the client. The alliance strengthens when the therapist and the client engage in a nurturing, supportive, trusting, empathetic, and respectful relationship, improving therapeutic outcomes. Therapists must monitor this relationship...
The Therapeutic Alliance
The therapeutic alliance refers to the relationship between the therapist and the client. The alliance strengthens when the therapist and the client engage in a nurturing, supportive, trusting, empathetic, and respectful relationship, improving therapeutic outcomes. Therapists must monitor this relationship...
112
Antidepressant Drugs: MAOIs and Other Agents
340
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
340


